Daniel Finkelstein, MD in Chevy Chase, MD - Medicare Pediatric Medicine

Daniel Finkelstein, MD is a medicare enrolled "Pediatrics" physician in Chevy Chase, Maryland. He went to Hahnemann University College Of Medicine and graduated in 2000 and has 24 years of diverse experience with area of expertise as Pediatric Medicine. He is a member of the group practice Privia Care Center Llc and his current practice location is 8401 Connecticut Ave, 201, Chevy Chase, Maryland. You can reach out to his office (for appointments etc.) via phone at (301) 907-3960.

Daniel Finkelstein is licensed to practice in Maryland (license number D0061574) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1902870926.

Contact Information

	Daniel Finkelstein, MD
	8401 Connecticut Ave, 201, Chevy Chase, MD 20815
	(301) 907-3960
	(240) 482-1541

Physician's Profile

Full Name	Daniel Finkelstein
Gender	Male
Speciality	Pediatric Medicine
Experience	24 Years
Location	8401 Connecticut Ave, Chevy Chase, Maryland
Accepts Medicare Assignments	Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Daniel Finkelstein attended and graduated from Hahnemann University College Of Medicine in 2000

NPI Data:

NPI Number: 1902870926
Provider Enumeration Date: 02/15/2006
Last Update Date: 07/08/2007

Medicare PECOS Information:

PECOS PAC ID: 5092948372
Enrollment ID: I20140513000782

Medical Identifiers

Medical identifiers for Daniel Finkelstein such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1902870926	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
208000000X	Pediatrics	D0061574 (Maryland)	Primary

Group Practice Association

Group Practice Name	Group PECOS PAC ID	No. of Members
Privia Care Center Llc	3274801139	192

News Archive

SynergEyes wins the 22nd annual Most Innovative New Product Award for 2009

CONNECT(R), one of the nation's most successful organizations dedicated to creating and sustaining the growth of innovative technology and life science businesses, announced SynergEyes, Inc., the high Dk hybrid contact lens manufacturer, as the winner of its 22nd annual Most Innovative New Product (MIP) Award for 2009.

Hope for fertility spreads through postcards

The campaign sends a multiplied message of hope for fertility in form of postcards with stories, including the key message on prevention and treatment. Thousands of postcards with moving stories are expected to cross Europe until October 2011.

HIMSS continues to add new health informations to Meaningful Use Onesource

Providing current and vital resources for implementation of health information technology to improve patient care, HIMSS continues to add new information to Meaningful Use OneSource, an online repository of hundreds of documents, tools and links to other knowledge available on the Internet.

Salk scientists uncover enzyme responsible for suppressing deadly lung cancer

Scientists at the Salk Institute have uncovered a molecule whose mutation leads to the aggressive growth of a common and deadly type of lung cancer in humans.

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Daniel Finkelstein allows following entities to bill medicare on his behalf.

Entity Name	Privia Medical Group Llc
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1013042480 PECOS PAC ID: 4385682061 Enrollment ID: O20050422000298

News Archive

SynergEyes wins the 22nd annual Most Innovative New Product Award for 2009

Hope for fertility spreads through postcards

HIMSS continues to add new health informations to Meaningful Use Onesource

Salk scientists uncover enzyme responsible for suppressing deadly lung cancer

Scientists at the Salk Institute have uncovered a molecule whose mutation leads to the aggressive growth of a common and deadly type of lung cancer in humans.

Entity Name	Privia Care Center Llc
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1164874426 PECOS PAC ID: 3274801139 Enrollment ID: O20170616001775

SynergEyes wins the 22nd annual Most Innovative New Product Award for 2009

Hope for fertility spreads through postcards

HIMSS continues to add new health informations to Meaningful Use Onesource

Salk scientists uncover enzyme responsible for suppressing deadly lung cancer

Scientists at the Salk Institute have uncovered a molecule whose mutation leads to the aggressive growth of a common and deadly type of lung cancer in humans.

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Daniel Finkelstein is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Daniel Finkelstein, MD 3376 Stuyvesant Pl, Washington, DC 20015 Ph: (202) 895-0999	Daniel Finkelstein, MD 8401 Connecticut Ave, 201, Chevy Chase, MD 20815 Ph: (301) 907-3960

News Archive

SynergEyes wins the 22nd annual Most Innovative New Product Award for 2009

Hope for fertility spreads through postcards

HIMSS continues to add new health informations to Meaningful Use Onesource

Salk scientists uncover enzyme responsible for suppressing deadly lung cancer

Scientists at the Salk Institute have uncovered a molecule whose mutation leads to the aggressive growth of a common and deadly type of lung cancer in humans.

Pediatrics Doctors in Chevy Chase, MD

Mrs. Linda Goldstein, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 4601 N Park Ave, Suite 8c, Chevy Chase, MD 20815 Phone: 301-656-2745 Fax: 301-718-7681
Rebecca M Gross, MD Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 8401 Connecticut Ave Ph Suite, Chevy Chase, MD 20815 Phone: 301-942-2122 Fax: 301-942-1149
Ryan Mcdonald Walley, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 8401 Connecticut Ave Ste 201, Chevy Chase, MD 20815 Phone: 301-907-3960 Fax: 301-652-4933
Katharina Blunschi, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 8401 Connecticut Ave, Chevy Chase, MD 20815 Phone: 301-907-3960
John F. O'neill, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2 Wisconsin Cir, Suite 200, Chevy Chase, MD 20815 Phone: 301-215-7100
Dr. Gary Don Crouch, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 8017 Glengalen Ln, Chevy Chase, MD 20815 Phone: 301-951-8001
Deborah Lindsey, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 6008 Highland Dr, Chevy Chase, MD 20815 Phone: 301-651-2320 Fax: 301-652-7116

Daniel Finkelstein, MD - Medicare Pediatric Medicine in Chevy Chase, MD

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Group Practice Association

SynergEyes wins the 22nd annual Most Innovative New Product Award for 2009

Hope for fertility spreads through postcards

HIMSS continues to add new health informations to Meaningful Use Onesource

Salk scientists uncover enzyme responsible for suppressing deadly lung cancer

Medicare Reassignments

SynergEyes wins the 22nd annual Most Innovative New Product Award for 2009

Hope for fertility spreads through postcards

HIMSS continues to add new health informations to Meaningful Use Onesource

Salk scientists uncover enzyme responsible for suppressing deadly lung cancer

SynergEyes wins the 22nd annual Most Innovative New Product Award for 2009

Hope for fertility spreads through postcards

HIMSS continues to add new health informations to Meaningful Use Onesource

Salk scientists uncover enzyme responsible for suppressing deadly lung cancer

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

SynergEyes wins the 22nd annual Most Innovative New Product Award for 2009

Hope for fertility spreads through postcards

HIMSS continues to add new health informations to Meaningful Use Onesource

Salk scientists uncover enzyme responsible for suppressing deadly lung cancer

Pediatrics Doctors in Chevy Chase, MD